跳至主要内容
临床试验/NL-OMON36969
NL-OMON36969已完成不适用

The effect of moderate alcohol consumption on subsequent food reward - The effect of alcohol on food reward

TNO0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Caucasian men, this means that at least both parents and the subject himself should be of the Caucasian race;
  • 2. Age 25-50 years (inclusive) on the day of the screening;
  • 3. Body Mass Index (BMI) of 20-25 kg/m2 (inclusive);
  • 4. Body weight of 60-100 kg (inclusive);
  • 5. Able to read, write and fully understand the Dutch language, and
  • 6. Able to participate in the study, willing to give written informed consent and to comply with the study procedures and restrictions

排除标准

  • 1. Above average score (>2.26) on the restrained eating scale of the Dutch Eating Behaviour Questionnaire;
  • 2. Alcohol consumption <=5 and >= 21 standard glasses/week;
  • 3. Not having regular and normal Dutch eating habits (consuming mostly 3 main meals including breakfast);
  • 4. Not having a normal day/night rhythm;
  • 5. Smoking, or stopped with smoking <3 months prior to start of the study;
  • 6. Using drugs, or stopped using drugs <3 months prior to start of the study;
  • 7. Having a (family) history of alcohol or drug related problems;
  • 8. Reported slimming or being on a medically described diet;
  • 9. Having a vegan, vegetarian or macrobiotic lifestyle;
  • 10. Loss of blood outside the limits of Sanquin within 3 months prior to screening;
  • 11. Participation in a clinical trial within 3 months prior to the start of this study or more than 4 times a year;
  • 12. Having a food allergy, sensitivity or disliking of one of the foods used in the study;
  • 13. Reported unexplained weight loss or gain of >4 kg in the month prior to screening;
  • 14. Inappropriate veins for cannula insertion;
  • 15. Not having a general practitioner or health insurance;
  • 16. Having a history of medical or surgical events or disease that may significantly affect the study outcome, particularly physiological disorders, metabolic or endocrine disease and gastrointestinal disorders; and/or
  • 17. Any conditions which, in the opinion of the investigator, might create undue risk to the subject or interfere with the subject's ability to comply with the protocol.

研究者

发起方
TNO

相似试验